Welcome to our database of vaccination related data. Please use the field below to search for relevant information.

Search:
Total Records Found: 223, showing 100 per page
TitleSummaryPreviewLinkDocument
TitleSummaryPreviewLinkDocument
Meningococcal diseases reporting/notifications vs laboratory confirmed diagnosis and cases reported not in line with laboratory confirmed Commun Dis Rep CDR Rev. 1997 Apr 4;7(4):R49-54.
Merck accused of massive MMR fraud (measles, mumps, rubella vaccine) www.huffingtonpost.ca/lawrence-solomon/merck-whistleblowers_b_5881914.html
Mercury and autism: accelerating evidence? Neuro Endocrinol Lett. 2005 Oct;26(5):439-46
MMR adverse reactions recorded in the UK since 1987 As of Feb 2014; data obtained from the MHRA yellow card scheme mmr_dap.pdf
MMR and autoimmune disease Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature: "Immune thrombocytopenia is a rare complication of the MMR vaccine that physicians should be aware of." www.ncbi.nlm.nih.gov/pubmed/25507234
MMR risk - former chief scientific officer quoted in Daily Mail There are very powerful people in positions of great authority in Britain and elsewhere who have staked their reputations and careers on the safety of MMR and they are willing to do almost anything to protect themselves. Daily Mail article
MMR vaccination associated with Crohn's Disease Wien Klin Wochenschr. 2015 Mar 28
MMR vaccines safety studies inadequate - Cochrane review 2011 The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. The evidence of adverse events following immunisation with the MMR vaccine cannot be separated from its role in preventing the target diseases. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD004407 cd004407_abstract.pdf
More doses of vaccines lead to higher rate of deaths and hospitalisations (safety, adverse events) Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on theHigh Vaccine Adverse Event Reporting System (VAERS), 1990–2010 Hum Exp Toxicol October 2012 vol. 31 no. 10 1012-1021
More evidence of asthma - vaccinations link USA 2000 The odds of having a history of asthma was twice as great among vaccinated subjects than among unvaccinated subjects J Manipulative Physiol Ther. 2000 Feb;23(2):81-90
More evidence that mumps vaccination in its current form doesn't work An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland. Epidemiol Infect. 2017 Nov;145(15):3219-3225
More pneumococcal cases from non-vaccine serotypes Study from Spain 2009 shows once again that the vaccines appear only to cause the rate of disease to shift to non-vaccine serotypes. www.ncbi.nlm.nih.gov/pubmed/19673968
Mortality (deaths rate) from Diphtheria before and after vaccinations Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 diphtheria_deaths_1.png
Mortality (deaths) from Measles (graph) Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 measles_deaths_1.png
Mortality (deaths) from Pertussis / Whooping Cough Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 pertussis_deaths_1.png
Mortality from meningococcal infections Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 meningococcal_deaths_zoomed_1.png
Most measles cases are NOT measles when tested Measles notifications and confirmed cases (by salivary testing only) England & Wales 1995-2004 by quarter www.vaccination-information-portal.com/wp-content/uploads/HPA.pdf
Mumps - no evidence it causes infertility Health Protection Agency webpage, now archived, proves fear of infertility from mumps unfounded. webarchive.nationalarchives.gov.uk/20140505192926/www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Mumps/GeneralInformation/mumpsGeneralInfo/
Mumps despite vaccination and high antibody count (immunogenicity, antibodies, vaccine failure) The study found students getting ill from Mumps despite high IgG titers - recommends more vaccinations www.ncbi.nlm.nih.gov/pubmed/17498856
Mumps outbreak in Washington 2017 - all patients were vaccinated "All mumps patients had received ≥2 documented doses of measles-mumps-rubella (MMR) vaccine, as is currently recommended" MMWR Morb Mortal Wkly Rep 2017;66:1307–1308.
Mumps vaccination ineffective (1) In Scotland in a 2011 outbreak, 45% of patients were fully vaccinated and another 28% partially so. www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19803
Mumps vaccination ineffective (10) In 2007/2008 in Moldova 96% of Mumps cases had had at least one dose of MMR www.ncbi.nlm.nih.gov/pubmed/20308934
Mumps vaccination ineffective (11) 100% of children in this outbreak in a school in Spain in 2000 were properly vaccinated. www.ncbi.nlm.nih.gov/pmc/articles/PMC2869917/ 12558338.pdf
Mumps vaccination ineffective (12) Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. www.ncbi.nlm.nih.gov/pubmed/19697404
Mumps vaccination ineffective (13) A 2006 report into Mumps outbreaks in Nova Scotia found 100% of cases had had MMR vaccinations and results don't seem to vary between one or two doses. www.ncbi.nlm.nih.gov/pubmed/16940266
Mumps vaccination ineffective (2) In a 2006 nationwide epidemic in the US, 63% of mumps cases happened despite two doses of MMR. www.ncbi.nlm.nih.gov/pubmed/19815120
Mumps vaccination ineffective (3) A 2013 study in the US Territory of Guam found that among all the mumps cases in school-age patients, 93% had had 2 doses of MMR www.ncbi.nlm.nih.gov/pubmed/23099425
Mumps vaccination ineffective (4) In Walsall, UK, in 2000, 68% of cases occurred in patients who had had at least one MMR shot. www.ncbi.nlm.nih.gov/pubmed/12718822
Mumps vaccination ineffective (5) In 1991, an outbreak in Tennessee, USA, occurred in a school where 98% of students were vaccinated. Among 68 students who got ill with mumps, 67 had been vaccinated. www.ncbi.nlm.nih.gov/pubmed/8277201
Mumps vaccination ineffective (6) 1980s outbreak in Kansas: 97.6% had been vaccinated against Mumps www.ncbi.nlm.nih.gov/pubmed/1861205
Mumps vaccination ineffective (7) During a Mumps outbreak in 1990 among a high school population, 95% of the students were vaccinated and out of 54 students who got mumps, 53 were vaccinated. www.ncbi.nlm.nih.gov/pubmed/7795768
Mumps vaccination ineffective (8) In a 2007-2008 outbreak among Australian Aboriginals, 52% had had 2 doses of MMR and among the age group with the highest incidence rate, 92% had been vaccinated. www.ncbi.nlm.nih.gov/pubmed/19807634
Mumps vaccination ineffective (9) A total of 52.4% of the cases were found to have been administered some dose of vaccine, 69.7% of them with two doses and 71.1% some Jeryl Lynn strain. www.ncbi.nlm.nih.gov/pubmed/18347744
Natural mumps immunity superior to that from vaccines In this study from the Czech Republic 19% of vaccinated individuals were immune, but 48% of those not vaccinated, confirming the problem of waning vaccine-induced immunity. Serological Survey of Mumps Antibodies in Adults in the Czech Republic and the Need for Changes to the Vaccination Strategy
No differnce in vaccination status between polio patients and controls During an outbreak in India in 1999, polio patients and controls had the same amount of vaccinations. www.ncbi.nlm.nih.gov/pubmed/12714548
No evidence that influenza vaccination in healthcare workers protects the elderly they look after Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD005187
No evidence that pneumococcal vaccination in pregnancy prevents infant infection There is insufficient evidence to assess whether pneumococcal vaccination during pregnancy could reduce infant infections. onlinelibrary.wiley.com/doi/10.1002/14651858.CD004903.pub4/full
No naturally acquired polio case in the UK since 1984 www.nhs.uk/conditions/polio-and-post-polio-syndrome-/pages/introduction.aspx
No protective effect from pertussis vaccinations in 1970s Shetland www.ncbi.nlm.nih.gov/pmc/articles/PMC1599131/
Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity This study is published in a reputable journal and effectively says that aluminium adjuvants in vaccines have neurotoxic effects at low doses when injected in mice. The mice who had higher doses had no such effects, raising all sorts of questions about the current assumptions on the safety of aluminium adjuvants. "As a possible consequence, comparing vaccine adjuvant exposure to other non- relevant aluminium exposures, e.g. soluble aluminium and other routes of exposure, may not represent valid approaches." "In the context of massive development of vaccine-based strategies worldwide, the present study may suggest that aluminium adjuvant toxicokinetics and safety require reevaluation." non-linear-dose-response-of-aluminium-hydroxide-adjuvant-particles-selective-low-dose-neurotoxicity.pdf
Pertussis among higly-vaccinated population in Wisconsin 2003-2004 50% of case patients had had 5 or more pertussis-containing vaccines. www.ncbi.nlm.nih.gov/pubmed/18180417
Pertussis and antibiotics: no benefit Antibiotics kill the bacterium but have no impact on clinical symptoms, nor do they prevent spreading Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD004404.
Pertussis cases by vaccination status 2013 USA - most were fully vaccinated Official survey by the CDC shows the majority of pertussis patients were vaccinated. cdcpertussissurvey.pdf
Pertussis statistics for England and Wales As published by Public Health England 2014 pertussis_notifications_and_deaths.pdf
Pertussis vaccinations: evidence of waning immunity Swedish study suggests vaccine protection wanes after 5 years. Most disease incidents in unvaccinated infants. www.ncbi.nlm.nih.gov/pubmed/16950988
Pertussis vaccinations: waning immunity and low effectiveness Norway 2012 study Incidence in children under the age of five years has not changed much over the fifteen year time period, however incidence in teenagers and young adults (10–40 yrs) has increased dramatically. Children between the ages of five and ten years experienced an increase in incidence from 1997 until the introduction of the childhood booster vaccine in 2006, and have now returned approximately to their 1997 levels. In contrast, there was a milder downturn in incidence in 10–19 year olds in 2006, followed by an increase a few years later."<br /><br />"By age 14 over 90% of cases occurred in vaccinated hosts, which, in the absence of loss of immunity, would indicate vaccine efficacy below 30%. These results therefore provide strong evidence that vaccine-induced immunity wanes over time. www.ncbi.nlm.nih.gov/pmc/articles/PMC3246080/
Pertussis vaccine low effectiveness / waning immunity Massachusetts 1992 Review of vaccination records indicated that 209 (96%) students had received four or more doses of pertussis-containing vaccine. www.cdc.gov/mmwr/preview/mmwrhtml/00020038.htm%5C
Pertussis vaccine spreads pertussis This research credits pertussis vaccines with being protective and at the same time says the vaccine aids pertussis colonization, hence spreading the disease. www.cidd.psu.edu/research/synopses/acellular-vaccine-enhancement-b.-parapertussis
Pharmaceutical industry criminal behaviour (fines, penalties, crime, prosecution) Although the full text articles is posted on a vaccination-critical website, an excerpt can also be found on the website of the British Medical Journal, where it was published: http://www.bmj.com/content/347/bmj.f7507 British Medical Journal Dec 18, 2013
Pneumococcal conjugate vaccine adverse reactions since 1987 UK As of Feb 2014; obtained from the MHRA Yellow Card scheme pneumococcal_conjugatevaccine.pdf
Pneumococcal diseases: higher rate post-vaccine In Canada it was found that the number of complicated pneumonia cases in children increased slightly after the vaccine was introduced. Cases shifted to non-vaccine serotypes. www.ncbi.nlm.nih.gov/pubmed/20383524
Pneumococcal vaccination during pregnancy There was no evidence that pneumococcal vaccination during pregnancy reduces the risk of neonatal infection Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No.: CD004903 cd004903_abstract.pdf
Pneumococcal vaccination: Little to now effect on acute otitis media 2013 Cochrane review of 9 randomized controlled trials Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD001480 cd001480_abstract.pdf
Pneumococcal vaccination: no benefit for COPD sufferers The limited evidence from randomised controlled trials (RCTs) included in this review suggests that, while it is possible that injectable polyvalent pneumococcal vaccines may provide some protection against morbidity in persons with COPD, no significant effect on any of the outcomes was shown. onlinelibrary.wiley.com/doi/10.1002/14651858.CD001390.pub3/abstract cd001390_abstract.pdf
Pneumococcal vaccine 23% effective - Philippines 2009 22.9% reduction of community-acquired pneumonia in children younger than 2 years of age... a reduction similar as observed in other trials. We could not demonstrate any vaccine effectiveness against clinical pneumonia. www.ncbi.nlm.nih.gov/pubmed/19483514
Pneumococcal vaccine 37% effective in Gambian trial (Lancet 2006) 333 of 8189 children given vaccine had an episode of radiological pneumonia compared with 513 of 8151 who received placebo. Pneumococcal vaccine efficacy was 37% www.ncbi.nlm.nih.gov/pubmed/15794968
Pneumococcal vaccine fairly effective for right serotypes - shift to non-vaccine serotypes Disease rates decreased for serotypes contained in the vaccine but increased for other serotypes, leading to an increase of cases overall. www.ncbi.nlm.nih.gov/pubmed/19508165
Pneumococcal vaccine: more hospitalizations since introduction Massachusetts study finds more children are hospitalised from invasive pneumococcal disease (IPD) since the introduction of the 13-valent pneumococcal vaccine. There was no change in mortality rates. The rate of IPD caused by pneumococcal serotypes contained in the vaccine did decrease, but only by 18%. www.ncbi.nlm.nih.gov/pubmed/25002663
Pneumococcal vaccines for sickle cell disease Vaccine failed to reduce illness but still gets recommended for reasons of immunogenicity Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003885
Polio in India eradicated, NPAFP paralysis increased The rise in non-polio acute flaccid paralysis was proportional to the doses of vaccine given. Indian J Med Ethics. 2012 Apr-Jun;9(2):114-7
Polio mortality (deaths) Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 polio_deathsv2_1.png
Polio provocation by DTP vaccine (diphtheria, tetanus, pertussis) J Infect Dis. 1992 Mar;165(3):444-9.
Polio provocation through injections and tonsillectomy Polio can be provoked by tonsillectomy, childhood immunisations and other medical interventions. www.cam.ac.uk/research/features/polio-provocation-the-health-debate-that-refused-to-go-away
Polio vs AFP worldwide trend WHO data shows a long-term increase in acute flaccid paralysis (AFP) worldwide against the falling polio count extranet.who.int/polis/public/CaseCount.aspx screen_shot_2015-01-19_at_11-29-30_1.png
Polio: definition of diagnostic criteria accounts for fall The Present Status of Polio Vaccines, Illinois Medical Journal, August 1960: change in definition removed most polio cases from statistics; the vaccine was credited with the improvement ratner_1960.pdf
Post-vaccination CNS demyelinating syndromes (safety, side-effects, adverse reactions, SAE) Autoimmun Rev. 2014 Mar;13(3):215-24.
Rare example of investigated SIDS after vaccination (sudden infant death) ...allows us to conclude that acute respiratory failure likely due to post hexavalent immunization-related shock was the cause of death. Forensic Sci Int. 2008 Aug 6;179(2-3):e25-9.
Reduced Asthma risk if vaccinations delayed Among 11, 531 children who received at least 4 doses of DPT, the risk of asthma was reduced to (1/2) in children whose first dose of DPT was delayed by more than 2 months. The likelihood of asthma in children with delays in all 3 doses was 0.39 J Allergy Clin Immunol. 2008 Mar;121(3):626-31.
Rise in autistic disorders linked to vaccines using human fetal cells Journal of Public Health and Epidemiology Vol. 6(9), pp. 271-284, September 2014 article1409245960_deisher_et_al.pdf
Rotavirus vaccinations seem to "work better" in rich countries Why does Rotavirus vaccine effectiveness appear to be lower in middle-income countries as opposed to high-income countries? A study attempting to investigate rotavirus strain-specific vaccine effectiveness shows results are lower in the lower income countries but the authors do not comment further on this. www.ncbi.nlm.nih.gov/pubmed/25082561
Rotavirus vaccine shedding Rotavirus antigen was detected as early as post-vaccination day 3 and as late as day 9, with peak numbers of shedding on post-vaccination days 6 through 8. Vaccine. 2011 May 31;29(24):4151-5. doi: 10.1016/j.vaccine.2011.03.074. Epub 2011 Apr 6.
Rotavirus vaccine, intussusception, side-effects, France, removed, Rotateq, Rotarix France removed the rotavirus vaccine from its vaccination schedule due to safety concerns http://www.bmj.com/content/350/bmj.h2867/rr-1
Rotavirus vaccines adverse reactions since 2008 UK As of Feb 2014; obtained from the MHRA Yellow Card scheme rotavirus.pdf
Rotavirus: natural immunity acquired gradually Natural infection also seems to impart impart immunity to multiple serotypes. www.ncbi.nlm.nih.gov/pubmed/19252424
Rubella shifted into older age groups (CRS) CDC data confirms the shift of Rubella cases into the 15+ age group, when CRS becomes a risk. www.cdc.gov/vaccines/pubs/pinkbook/rubella.html#epi
Rubella vaccination ineffective / natural immunity superior A 1970 study comparing reinfection rates between naturally immune individuals and those who have been vaccinated. horstman-et-al-rubella-reinfection-of-vaccinated-and-naturally-immune-persons-exposed-in-an-epidemic-1970new-england-journal-of-medicine.pdf
Rubella vaccinations increase CRS risk (Canada, 2014) Vaccinations against Rubella have left pregnant women at HIGHER risk of Congenital Rubella Syndrome in Canada. www.ncbi.nlm.nih.gov/pubmed/25533327
Rubella vaccine and MMR possible Autism link (Chaudhuri) A paper suggesting live Rubella virus from vaccine could trigger Autism chaudhurirubellaautism.pdf
Rubella vaccine lack of long-term protection (CRS) Women no longer protected once they reach child-bearing age www.ncbi.nlm.nih.gov/pubmed/12690271
Seasonal Flu vaccine 2013/2014 England: effectiveness During 2013/14 flu season, routine flu vaccinations for children showed no or only statistically insignificant effects in England www.ncbi.nlm.nih.gov/pubmed/24925457
Seasonal influenza vaccine 26%-73% effective in UK study 2012/13 Seasonal influenza vaccine 26%-73% effective in UK study 2012/13 www.ncbi.nlm.nih.gov/pubmed/25033051
Selective publication of industry-sponsored vaccination clinical trials Independent studies 4 times more likely to report negative results; mainly the positive ones get published by industry www.bmj.com/content/348/bmj.g3058
Severe tetanus in immunized patients with high anti-tetanus titers Severe (grade III) tetanus occurred in three immunized patients who had high serum levels of anti-tetanus antibody. The disease was fatal in one patient. One patient had been hyperimmunized to produce commercial tetanus immune globulin. Two patients had received immunizations 1 year before presentation. www.ncbi.nlm.nih.gov/pubmed/1565228
SIDS (sudden infant death) following hexavalent vaccination Herein we report the case of a 3-month-old female infant dying suddenly and unexpectedly shortly after being given a hexavalent vaccination. Virchows Arch. 2006 Jan;448(1):100-4. Epub 2005 Oct 18.
Studies by Shaw, Seneff etc on Aluminuim, adjuvants, vaccines link to autism and similar Link to dropbox folder www.dropbox.com/sh/7jt905c1gw9c6sn/AADMvwxDhNGg2k3fH0nUaMMea?dl=0
Suspected vs confirmed pertussis cases in Canada study In Alberta, Canada, only 7% of suspected pertussis cases were confirmed to be so by laboratory tests. www.ncbi.nlm.nih.gov/pmc/articles/PMC3931923/
Tdap vaccines: evidence of rapidly waning immunity Study suggests Tdap vaccine effectiveness reduces from 75% to 12% after 3 years. www.ncbi.nlm.nih.gov/pmc/articles/PMC4132910/#__articleid1052015aff-info
Temporal Association of Certain Neuropsychiatric Disorders Following Vaccination of Children and Adolescents: A Pilot Case–Control Study "This pilot epidemiologic analysis implies that the onset of some neuropsychiatric disorders may be temporally related to prior vaccinations in a subset of individuals. " Front. Psychiatry 8:3. doi: 10.3389/fpsyt.2017.00003
Tetanus cases vaccinated vs unvaccinated (Finland 1969-85) 5 children and 101 adults were the only Tetanus cases in Finland in this 15 year period. 4 out of the 5 children were adequately vaccinated. www.ncbi.nlm.nih.gov/pubmed/8335151
Tetanus mortality (deaths) graph Office of National Statistics 20th Century Mortality Files - England and Wales 1901 - 2000 tetanus_deaths_1.png
Tetanus: Vitamin C cautiously considered as possible treatment Further trials are needed to confirm the outcome. onlinelibrary.wiley.com/doi/10.1002/14651858.CD006665.pub3/abstract
The unofficial vaccine educators: are CDC funded non-profits sufficiently independent? BMJ Associate Editor Peter Doshi investigates the semi-transparent world of vaccine advocacy organizations bmj-j5104-full.pdf
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. Folia Neuropathol 2010; 48 (4): 258-269
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 2 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. J Toxicol. 2013;2013:801517.
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 3 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. Mol Psychiatry. 2004 Apr;9(4):358-70.
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 4 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. J Child Neurol November 2007 vol. 22 no. 11 1308-1311
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 5 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. Neurotoxicology. 2005 Jan;26(1):1-8.
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 6 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. J Neurol Sci. 2008 Aug 15;271(1-2):110-8.
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 7 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. Cell Biol Toxicol. 2010 Apr;26(2):143-52
Thimerosal (mercury) link to neurodeve­lopmental disorders (autism) 8 Thimerosal is still contained in trace amounts in vaccines and as preservatives in some flu vaccines. Neurochem Res. 2011 Jun;36(6):927-38